Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK

Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation

(2014) L. Webster et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

(2014) William D. Chey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management

(2014) Lalit Kumar et al.   Gastroenterology Research and Practice

Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis

(2012) William Dunlop et al.   JOURNAL OF MEDICAL ECONOMICS

PGI7 ECONOMIC BURDEN OF OPIOID INDUCED CONSTIPATION IN SPAIN

(2011) P Guijarro et al.   VALUE IN HEALTH

The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)

(2008) Timothy J. Bell et al.   PAIN MEDICINE